Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...

Key findings included 94% of test-phase responders experienced at least a 50% decrease in episodes of UUI.

Cognito Therapeutics today announced that it completed the final close of its oversubscribed Series C financing round.

Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...

NEW DELHI, March 10, 2026 /PRNewswire/ -- The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of progressive neurological disorders across ...

A merry little surge of electricity piped by automatic alarm from the mood organ beside his bed awakened Rick Deckard.” The characters in Philip K.

Initial management of OAB generally involves behavioral modifications, pharmacotherapy, and physical therapy, which may be used alone or in combination. Neuromodulation offers a novel approach to ...